首页 | 官方网站   微博 | 高级检索  
     

肠胃清药物血清对人结肠癌细胞株HCT-8/V多药耐药的逆转作用及机制研究
引用本文:鲍文磊,孙珏,范忠泽,许建华,邓皖利.肠胃清药物血清对人结肠癌细胞株HCT-8/V多药耐药的逆转作用及机制研究[J].辽宁中医杂志,2009(3):464-466.
作者姓名:鲍文磊  孙珏  范忠泽  许建华  邓皖利
作者单位:上海中医药大学附属普陀医院肿瘤科;
基金项目:国家自然科学基金项目(30672683);;上海市教委资助项目(05CZ16)
摘    要:目的:研究肠胃清方对大肠癌耐药细胞株HCT-8/V的逆转作用及其抑制P-gp表达的影响。方法:MTT法测定肠胃清对HCT-8/V细胞株的逆转作用,流式细胞术测定P糖蛋白(P-gp)的表达。结果:HCT-8/V细胞株对VCR、DDP、5-FU、MMC的耐药指数分别为18.6、22.3、4.3、3.7。经肠胃清方药物血清作用48h后,其对化疗的耐药性显著下降,对VCR、DDP的逆转指数分别为3.3和7.5,静息状态下HCT-8/V细胞的P-gp表达显著高于HCT-8(P<0.01),而经肠胃清药物血清作用后P-gp表达显著降低(P<0.01)。结论:肠胃清方可以逆转人大肠癌耐药细胞株HCT-8/V的多药耐药性,其机制可能与其下调P-gp的表达有关。

关 键 词:肠胃清方  多药耐药  大肠癌  P糖蛋白

Reversal of Multidrug Resistance of Human Intestinal Cancer Cell Line HCT-8/V and its Mechanism by Changweiqing Serum
BAO Wen-lei,SUN Jue,FAN Zhong-ze,XU Jian-hua,DENG Wan-li.Reversal of Multidrug Resistance of Human Intestinal Cancer Cell Line HCT-8/V and its Mechanism by Changweiqing Serum[J].Liaoning Journal of Traditional Chinese Medicine,2009(3):464-466.
Authors:BAO Wen-lei  SUN Jue  FAN Zhong-ze  XU Jian-hua  DENG Wan-li
Affiliation:Putuo Hospital Affiliated to Shanghai University of TCM;Shanghai 200062;China
Abstract:Objective:To investigate the reversal effect of Changweiqing on multidrug resistance of human intestinal cancer cell line HCT-8/V and the impact of Changweiqing to the expressions of P-gp in HCT-8/V.Methods:The reversal effect of Changweiqing was assayed by MTT assay,and the expressions of P-gp in HCT-8/V cell line was detected with flow cytometry(FCM).Results:The resistance factor(RF)of HCT-8/V cells to VCR,DDP,5-FU,MMC respectively were 18.6,22.3,4.3,3.7.After simultaneous treatment 48 hours with Changwei...
Keywords:Changweiqing  Multidrug resistance  Colorectal cancer  P-glycprotein  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号